CEBasic Materials · ChemicalsThe 16 Wall Street analysts covering Celanese Corp. hold a median 12-month price target of $63 — +39.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 56 of 100 as at 2 Sept 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores Celanese Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Accruals (92): Reported profit is backed by cash, and the company is not expanding recklessly.
Quality (28): Profits are thin or unreliable for the size of the business, or they are not turning into cash.
Size (23): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on CE, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +39.4% from it.
Of the 20 most recent actions, 0 moved their price target up and 3 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 6 Aug 2026 | Wells Fargo | Maintains | Overweight | $80 → $65 |
| 5 Aug 2026 | BMO Capital | Maintains | Market Perform | $57 → $54 |
| 16 July 2026 | Morgan Stanley | Maintains | Equal-Weight | $72 → $58 |
| 16 July 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 6 July 2026 | BMO Capital | Maintains | Market Perform | — |
| 1 July 2026 | Mizuho | Maintains | Neutral | — |
| 30 June 2026 | B of A Securities | Maintains | Buy | — |
| 24 June 2026 | Citigroup | Maintains | Buy | — |
| 12 May 2026 | JP Morgan | Upgrade | Overweight | — |
| 11 May 2026 | RBC Capital | Maintains | Sector Perform | — |
| 8 May 2026 | Wells Fargo | Maintains | Overweight | — |
| 7 May 2026 | Citigroup | Maintains | Buy | — |
| 7 May 2026 | JP Morgan | Maintains | Neutral | — |
| 6 May 2026 | Mizuho | Maintains | Neutral | — |
| 5 May 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 21 Apr 2026 | B of A Securities | Maintains | Buy | — |
| 16 Apr 2026 | Citigroup | Maintains | Buy | — |
| 10 Apr 2026 | Wells Fargo | Maintains | Overweight | — |
| 9 Apr 2026 | UBS | Maintains | Neutral | — |
| 31 Mar 2026 | Mizuho | Maintains | Neutral | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CE appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 3 Sept 2026, Celanese Corp. returned +1.5% against +21.4% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 64% of US stocks
Cheaper than 82% of US stocks
Cheaper than 67% of US stocks
Cheaper than 39% of US stocks
Higher than 49% of US stocks
Higher than 13% of US stocks
Higher than 25% of US stocks
Higher than 66% of US stocks
Higher than 19% of US stocks
Higher than 30% of US stocks
Higher than 62% of US stocks
Higher than 4% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Celanese Corp. has a market value of $5.1B and an enterprise value of $16.3B.
Revenue in the twelve months to 30 June 2026: $9.7B. The latest quarter grew 8.7% year on year.
Net income over the same four quarters: −$1.2B, a −11.9% net margin.
Diluted earnings per share, trailing twelve months: $−10.69.
Free cash flow in the twelve months to 30 June 2026: $708.0M, after $276.0M of capital spending.
Celanese Corp. spent $13.0M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 6.8×; forward P/E: 7.6× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.26%, paying out 28% of earnings.
Celanese Corp. employs 11,000 people — $883K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Celanese Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Celanese reported earnings 30 days ago, and its stock has risen 8.2% since that report. The article examines what may come next for the company's shares following this earnings release.
Why it matters — The stock's 8.2% gain since the earnings report signals investor confidence and is relevant for those tracking Celanese's post-earnings performance.
Celanese Corp. will sell an additional 19% stake in its food venture Nutrinova to Mitsui for $152 million, reducing its ownership to 11%. The company plans to use the proceeds to lower its net debt.
Why it matters — This divestiture provides Celanese with cash to reduce its debt while it retains a minority stake in the Nutrinova business.
Celanese Corp. announced it will sell additional shares of its Nutrinova joint venture to Mitsui & Co., Ltd. The announcement was made in a Business Wire release from the company's Dallas and Frankfurt offices.
Why it matters — The transaction changes Celanese's ownership position in the Nutrinova joint venture, which is relevant to understand for those monitoring the company's portfolio structure.
Celanese CFO Chuck Kyrish directly purchased 2,300 shares for approximately $105,000 on August 14, 2026, increasing his direct equity position by 9%.
Why it matters — An executive's direct share purchase is a notable insider transaction that CE watchers may view as a signal of confidence in the company.
Celanese is partnering with VIGOR to develop lightweight plastic joints for humanoid robots, aiming for a weight reduction of more than 30% in these components.
Why it matters — The partnership positions Celanese in the emerging humanoid robotics market, potentially expanding demand for its advanced materials.
The 16 Wall Street analysts covering Celanese Corp. have a median 12-month price target of $63, with estimates ranging from $45 to $86. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 16 analysts covering Celanese Corp., 10 rate it a Buy, 6 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Celanese Corp. 56 out of 100 across roughly 4,600 US stocks as at 2 Sept 2026. None of this is personal advice — it does not consider your circumstances.
As at 2 Sept 2026, Celanese Corp. ranks 56 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (92 of 100).
No one can know that. What the data says: the median 12-month target from 16 analysts implies +39.4% from the last close, and Ticker Nerd's factor model ranks Celanese Corp. 56 out of 100 as at 2 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Celanese Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CE are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $45 to $86 over the next 12 months.
Celanese Corp. returned +1.5% over the 12 months to 3 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
Celanese Corp. Common Stock is the publicly traded equity of Celanese Corporation, a global specialty materials and chemical company based in Irving, Texas.
The most recent item we track (Zacks Investment Research, 3 Sept 2026): "Why Is Celanese (CE) Up 8.2% Since Last Earnings Report?". Celanese reported earnings 30 days ago, and its stock has risen 8.2% since that report. The article examines what may come next for the company's shares following this earnings release.
Celanese Corp. Common Stock is the publicly traded equity of Celanese Corporation, a global specialty materials and chemical company based in Irving, Texas. The company develops and supplies engineered materials, acetyl chain products, and specialty chemical solutions used as essential inputs in industrial and consumer manufacturing. Its product portfolio includes high-performance polymers, acetyl intermediates, and related materials designed for applications in automotive, medical, electronics, construction, coatings, adhesives, and consumer goods. Celanese serves customers across North America, Europe, and Asia through a broad manufacturing and commercial network, with operations centered on supporting downstream industries that rely on consistent, specialized chemical performance. In the financial market, Celanese Corp. Common Stock represents ownership in a diversified industrial materials business with exposure to global demand for specialty chemicals and advanced polymer solutions.
CEO Mr. Scott A. Richardson · 11,000 employees · United States · https://www.celanese.com
